0001479290-23-000116.txt : 20231218 0001479290-23-000116.hdr.sgml : 20231218 20231218163222 ACCESSION NUMBER: 0001479290-23-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sjuts Dustin S CENTRAL INDEX KEY: 0001796224 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 231494222 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 wk-form4_1702935129.xml FORM 4 X0508 4 2023-12-15 0 0001479290 Revance Therapeutics, Inc. RVNC 0001796224 Sjuts Dustin S C/O REVANCE THERAPEUTICS, INC 1222 DEMONBREUN STREET, 20TH FLOOR NASHVILLE TN 37203 0 1 0 0 President 0 Common Stock 2023-12-15 4 F 0 4712 8.08 D 157354 D Represents the number of shares withheld by and surrendered to the Issuer on December 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award (the "RSA") for 11,973 shares. The RSA vests in three equal annual installments from December 15, 2021. /s/ Dwight Moxie, Attorney-in-Fact 2023-12-18